Interestingly, introducing both CD34+ and CD33+my cell sensitivity to α-bisabolol (as the mean value of 5 cases) in clustering analysis made it evident that ALL cells as a whole were more sensitive to α-bisabolol than their normal counterpart (grouped into cluster 3 among less sensitive cells). The gene discussed is CD33; the disease is acute lymphoblastic leukemia.